 1. If female, must be either postmenopausal, sterilised or, if sexually active, effectively practicing an acceptable method of contraception either oral, parenteral, or implantable hormonal contraceptives, intrauterine device or barrier and spermicide. Subjects must agree to use adequate contraception during the study and for at least 12 weeks or longer as per local requirement after the last dose of study treatment. 